MCIC (MultiCorp International) EBITDA Margin %: 0.00% (As of Sep. 2023)


What is MultiCorp International EBITDA Margin %?

MultiCorp International MCIC EBITDA Margin % is 0.00% as of Sep. 2023.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. MultiCorp International's EBITDA for the three months ended in Sep. 2023 was $-0.01 Mil. MultiCorp International's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, MultiCorp International's EBITDA margin for the quarter that ended in Sep. 2023 was 0.00%.

MultiCorp International  (OTCPK:MCIC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

MultiCorp International EBITDA Margin % Related Terms

MultiCorp International EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for MultiCorp International's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MultiCorp International EBITDA Margin % Chart

MultiCorp International Annual Data
Trend
EBITDA Margin %

MultiCorp International Quarterly Data
Jun21 Jun22 Sep22 Sep23
EBITDA Margin % 0.00 0.00 0.00 0.00

MCIC vs GPFT, KGKG, ERBB: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MultiCorp International's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MultiCorp International EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MultiCorp International's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where MultiCorp International's EBITDA Margin % falls into.


MultiCorp International EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

MultiCorp International's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

MultiCorp International's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-0.01/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
MultiCorp International (MCIC) has a EBITDA Margin % of 0.00% as of Sep. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MultiCorp International and its competitors.
Is MultiCorp International's EBITDA Margin % too high?
MultiCorp International's current EBITDA Margin % is 0.00%.
How does MultiCorp International's EBITDA Margin % compare to GPFT and KGKG?
MultiCorp International's EBITDA Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MultiCorp International and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MultiCorp International's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MultiCorp International stock overvalued right now?
MultiCorp International (MCIC) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MultiCorp International (MCIC), the current EBITDA Margin % is 0.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MultiCorp International Business Description

Address 5308 Derry Avenue, Suite R, Agoura Hills, CA, USA, 91301
MultiCorp International Inc buys and sells nitrile medically approved gloves and other PPE supplies to include gowns, masks and other items for the medical industry. The company is currently working on a medical app that will assist in monitoring potential life threatening scenarios.